Manufacturer of Controlled Substances; Notice of Application, 53606 [E7-18446]

Download as PDF 53606 Federal Register / Vol. 72, No. 181 / Wednesday, September 19, 2007 / Notices controlled substances may file comments or objections to the issuance of the proposed registration and may, at the same time, file a written request for a hearing on such application pursuant to 21 CFR 1301.43 and in such form as prescribed by 21 CFR 1316.47. Any such comments or objections being sent via regular mail should be addressed, in quintuplicate, to the Drug Enforcement Administration, Office of Diversion Control, Federal Register Representative (ODL), Washington, DC 20537, or any being sent via express mail should be sent to Drug Enforcement Administration, Office of Diversion Control, Federal Register Representative (ODL), 2401 JeffersonDavis Highway, Alexandria, Virginia 22301; and must be filed no later than October 19, 2007. This procedure is to be conducted simultaneously with and independent of the procedures described in 21 CFR 1301.34(b), (c), (d), (e), and (f). As noted in a previous notice published in the Federal Register on September 23, 1975, (40 FR 43745–43746), all applicants for registration to import a basic class of any controlled substances in Schedule I or II are and will continue to be required to demonstrate to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, that the requirements for such registration pursuant to 21 U.S.C. 958(a), 21 U.S.C. 823(a), and 21 CFR 1301.34(b), (c), (d), (e), and (f) are satisfied. Dated: September 12, 2007. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. E7–18497 Filed 9–18–07; 8:45 am] BILLING CODE 4410–09–P Drug Schedule Marihuana (7360) ......................... Cocaine (9041) ............................. I II The Institute will manufacture small quantities of cocaine and marihuana derivatives for use by their customers in analytical kits, reagents, and reference standards as directed by NIDA. Any other such applicant and any person who is presently registered with DEA to manufacture such a substance may file comments or objections to the issuance of the proposed registration pursuant to 21 CFR 1301.33(a). Any such written comments or objections being sent via regular mail should be addressed, in quintuplicate, to the Drug Enforcement Administration, Office of Diversion Control, Federal Register Representative (ODL), Washington, DC 20537, or any being sent via express mail should be sent to Drug Enforcement Administration, Office of Diversion Control, Federal Register Representative (ODL), 2401 Jefferson Davis Highway, Alexandria, Virginia 22301; and must be filed no later than November 19, 2007. Dated: September 12, 2007. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. E7–18446 Filed 9–18–07; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF LABOR Occupational Safety and Health Administration [Docket No. OSHA–2007–0064] Federal Advisory Council on Occupational Safety and Health (FACOSH): Announcement of Meeting Occupational Safety and Health Administration (OSHA), Labor. ACTION: Announcement of meeting. AGENCY: DEPARTMENT OF JUSTICE Drug Enforcement Administration rwilkins on PROD1PC63 with NOTICES Manufacturer of Controlled Substances; Notice of Application Pursuant to § 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on August 24, 2007, Research Triangle Institute, Kenneth H. Davis Jr., Hermann Building, P.O. Box 12194, East Institute Drive, Research Triangle, North Carolina 27709, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in schedules I and II: VerDate Aug<31>2005 16:58 Sep 18, 2007 Jkt 211001 SUMMARY: The Federal Advisory Council on Occupational Safety and Health (FACOSH) will meet October 11, 2007, in Washington, DC. DATES: FACOSH meeting: FACOSH will meet from 1 p.m. to 4:30 p.m., Thursday, October 11, 2007. Submission of comments and requests to speak: Comments and requests to speak at the FACOSH meeting must be received by October 4, 2007. ADDRESSES: FACOSH meeting: FACOSH will meet in Room C–5521, Conference Room 4, U.S. Department of Labor, 200 Constitution Avenue, NW., Washington, DC 20210. PO 00000 Frm 00085 Fmt 4703 Sfmt 4703 Submission of comments and requests to speak: Comments and requests to speak at the FACOSH meeting, identified by OSHA Docket No. 2007– 0064, may be submitted by any of the following methods: Electronically: You may submit materials, including attachments, electronically at: http:// www.regulations.gov, the Federal eRulemaking Portal. Follow the online instructions for making submissions. Facsimile: If your submission, including attachments, is not longer than 10 pages, you may fax it to the OSHA Docket Office at (202) 693–1648. Mail, express delivery, hand delivery, messenger or courier service: Submit three copies of your submissions to the OSHA Docket Office, Room N–2625, U.S. Department of Labor, 200 Constitution Avenue, NW., Washington, DC 20210; telephone (202) 693–2350 (OSHA’s TTY number is (877) 889– 5627). Deliveries (hand, express mail, messenger and courier service) are accepted during the Department of Labor’s and OSHA Docket Office’s normal business hours, 8:15 a.m.–4:45 p.m., e.t. Instructions: All submissions must include the Agency name and docket number for this Federal Register notice (Docket No. OSHA–2007–0064). Submissions in response to this Federal Register notice, including personal information provided, will be posted without change at: http:// www.regulations.gov. Therefore, OSHA cautions interested parties about submitting personal information such as social security numbers and birth dates. Because of security-related procedures, submissions by regular mail may result in a significant delay in their receipt. Please contact the OSHA Docket Office, at the address above, for information about security procedures for making submissions by hand delivery, express delivery, and messenger or courier service. For additional information on submitting comments and requests to speak, see the SUPPLEMENTARY INFORMATION section below. Docket: To read or download submissions, go to http:// www.regulations.gov. All documents in the docket are listed in the http:// www.regulations.gov index. Although listed in the index, some documents (e.g., copyrighted material) are not publicly available to read or download through http://www.regulations.gov. All submissions, including copyrighted material, are available for inspection and copying at the OSHA Docket Office at the address above. FOR FURTHER INFORMATION CONTACT: For general information: Diane Brayden, E:\FR\FM\19SEN1.SGM 19SEN1

Agencies

[Federal Register Volume 72, Number 181 (Wednesday, September 19, 2007)]
[Notices]
[Page 53606]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-18446]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Sec.  1301.33(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on August 24, 2007, Research 
Triangle Institute, Kenneth H. Davis Jr., Hermann Building, P.O. Box 
12194, East Institute Drive, Research Triangle, North Carolina 27709, 
made application by renewal to the Drug Enforcement Administration 
(DEA) to be registered as a bulk manufacturer of the basic classes of 
controlled substances listed in schedules I and II:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Marihuana (7360)...........................  I
Cocaine (9041).............................  II
------------------------------------------------------------------------

    The Institute will manufacture small quantities of cocaine and 
marihuana derivatives for use by their customers in analytical kits, 
reagents, and reference standards as directed by NIDA.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such a substance may file comments or 
objections to the issuance of the proposed registration pursuant to 21 
CFR 1301.33(a).
    Any such written comments or objections being sent via regular mail 
should be addressed, in quintuplicate, to the Drug Enforcement 
Administration, Office of Diversion Control, Federal Register 
Representative (ODL), Washington, DC 20537, or any being sent via 
express mail should be sent to Drug Enforcement Administration, Office 
of Diversion Control, Federal Register Representative (ODL), 2401 
Jefferson Davis Highway, Alexandria, Virginia 22301; and must be filed 
no later than November 19, 2007.

    Dated: September 12, 2007.
 Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. E7-18446 Filed 9-18-07; 8:45 am]
BILLING CODE 4410-09-P